SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Galapagos Islands

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: gypsees who wrote (39388)5/13/2003 12:25:31 AM
From: 2MAR$  Read Replies (3) of 57110
 
Millennium Pharm downgraded by UBS Warburg to hold ...

oh , but that was on the 16th of april @$9 , oops .
stockcharts.com[h,a]daclyyay[pb50!b200][vc60][iUc20!La12,26,9]&pref=G

They burn cash with all contensious and controversial haste ... MLNM has the 3rd highest R&D spending of all the biotechies, Velcade drug partnership promotion still pending , and Bayer relationship may be ending in
sept (?)...but it is a growth stock again <G>

Anyways ...back in the Lab ...MLNM will be presenting an overview of Company progress towards 2003 goals @ Robert Baird 2003 Growth Stock Conference--->
tomorrow , Tues May 13 @ 10.30 CDT at the Four Seasons , Chicago

millennium.com

everything should be just fine and on track , now that next earnings are still so far away...

;-)
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext